| Autor: |
Sung Won LEE, Sangwook PARK |
| Jazyk: |
English<br />Korean |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Korean Journal of Clinical Laboratory Science, Vol 55, Iss 2, Pp 105-112 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
1738-3544 |
| DOI: |
10.15324/kjcls.2023.55.2.105 |
| Popis: |
Leucine-rich repeat kinase 2 (LRRK2) is known to play a crucial role in the pathophysiology of neurodegenerative disorders such as Parkinson’s disease. LRRK2 is predominantly expressed in the lung as well as the brain. However, it is unclear whether LRRK2 expression correlates with the pathogenesis of lung squamous cell carcinoma (LUSC). This study analyzes the prognostic significance of LRRK2 in LUSC using the Kaplan-Meier plotter tool. High expression of LRRK2 is known to be associated with a bad prognosis in patients with LUSC. Patients with high LRRK2 expression, tumor mutational burden, high neoantigen load, and even gender correlation reportedly have the worse survival rates. In the gene expression profiling interactive analysis (GEPIA) database, the severity of pathogenesis in LUSC with high LRRK2 expression positively corresponds to a high expression of anti-inflammatory cytokines but not inflammatory cytokines. Similarly, the increased expression of interleukin (IL)10-related genes was shown to be significantly linked in LRRK2-high LUSC patients having a poor prognosis. Moreover, the tumor immune estimation resource (TIMER) database suggests that macrophages are one of the cellular sources of IL10 in LRRK2-high LUSC patients. Collectively, our results demonstrate that the postulated LRRK2-IL10 axis is a potential therapeutic target and prognostic biomarker for LUSC. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
